Chicago Partners Investment Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-438
Closed -$76K 1044
2018
Q3
$76K Sell
438
-103
-19% -$18.9K 0.01% 458
2018
Q2
$90K Sell
541
-134
-20% -$21.5K 0.01% 400
2018
Q1
$114K Buy
675
+469
+228% +$78.7K 0.02% 329
2017
Q4
$34K Buy
206
+78
+61% +$14K 0.01% 519
2017
Q3
$26K Buy
128
+25
+24% +$5.81K ﹤0.01% 566
2017
Q2
$22K Hold
103
0.01% 510
2017
Q1
$25K Buy
+103
New +$24K 0.01% 390
2016
Q1
Sell
-296
Closed -$84.7K 498
2015
Q4
$92K Buy
+296
New +$88.1K 0.04% 239
2015
Q2
Sell
-68
Closed -$20.3K 495
2015
Q1
$18K Buy
+68
New +$19.4K 0.01% 300

Other funds holding AGN

Chicago Partners Investment Group's AGN Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 438 shares — an estimated $76K sold.

Chicago Partners Investment Group first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $114K in Q1 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 438 Allergan plc shares in Q4 2018, an estimated $76K.
  • Chicago Partners Investment Group first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Chicago Partners Investment Group's Allergan plc position peaked at $114K in Q1 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.